Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial
TNT with selective NOM is cost effective. The cost-effectiveness of CNCT with NOM relative to SOC is dependent on CNCT being made available to a sufficiently large proportion of patients with LARC. Additional analyses are needed to validate these findings from a societal perspective and in the context of other emerging treatment paradigms for LARC.
Authors
- Julio García‐Aguilar (ORCID: https://orcid.org/0000-0003-2451-0948)
- Andrew Briggs (ORCID: https://orcid.org/0000-0002-0777-1997)
- Maria Widmar (ORCID: https://orcid.org/0000-0002-1145-8370)
- Mason McCain (ORCID: https://orcid.org/0000-0002-8809-8342)
- Akriti Mishra Meza (ORCID: https://orcid.org/0000-0002-3477-5037)
- Charles A. Ternent (ORCID: https://orcid.org/0000-0003-0050-9723)
Institutions
- Creighton University (US)
- University of Nebraska at Omaha (US)
- Memorial Sloan Kettering Cancer Center (US)
- London School of Hygiene & Tropical Medicine (GB)
- Methodist Hospital (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1200/jco.24.00681
- Citations
- 5
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.41